Eliminating trachoma in areas with limited disease

被引：40

作者：

Gaynor, BD

Miao, YH

Cevallos, V

Jha, H

Chaudary, JSP

Bhatta, R

Osaki-Holm, S

Yi, E

Schachter, J

Whitcher, JP

Lietman, T ^{[1
]}

机构：

[1] Univ Calif San Francisco, WHO, Collaborating Ctr, Francis I Proctor Fdn,Dept Ophthalmol, San Francisco, CA 94143 USA

[2] Geta Eye Hosp, Geta, Nepal

来源：

EMERGING INFECTIOUS DISEASES | 2003年 / 9卷 / 05期

关键词：

D O I：

10.3201/eid0905.020577

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The common wisdom is that a trachoma program cannot eliminate ocular chlamydia from a community, just reduce infection to a level where blindness would be minimal. We describe the success of multiple mass antibiotic treatments, demonstrating that complete elimination of infection may be an attainable goal in an area with modest disease.

引用

页码：596 / 598

页数：3

共 16 条

[1]

Allee W.G., 1949, PRINCIPLES ANIMAL EC

[2] RANDOMIZED CONTROLLED TRIAL OF SINGLE-DOSE AZITHROMYCIN IN TREATMENT OF TRACHOMA [J].

BAILEY, RL ;

ARULLENDRAN, P ;

WHITTLE, HC ;

MABEY, DCW .

LANCET, 1993, 342 (8869) :453-456

[3]

Baral K, 1999, B WORLD HEALTH ORGAN, V77, P461

[4]

Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22

[5]

FOEGE W, 1988, B WORLD HEALTH ORGAN, V74, P109

[6]

GAYNOR BD, 2002, INT OPHTHALMOL CLIN, V43, P853

[7]

Hinman A R, 1998, Bull World Health Organ, V76 Suppl 2, P85

[8]

Holm SO, 2001, B WORLD HEALTH ORGAN, V79, P194

[9] Global elimination of trachoma: How frequently should we administer mass chemotherapy? [J].

Lietman, T ;

Porco, T ;

Dawson, C ;

Blower, S .

NATURE MEDICINE, 1999, 5 (05) :572-576

[10]

LIETMAN T, 1998, P 9 INT S HUM CHLAM, P259

← 1 2 →